A groundbreaking study presented at the American Heart Association’s Scientific Sessions 2023 unveils promising results for a ...

Karnataka: Shilpa Medicare has announced that the Company’' 100% subsidiary, Shilpa Pharma Lifesciences Limited has received ...

Jhansi: Days after the tragic fire at the Neonatal Intensive Care Unit (NICU) of Jhansi's Maharani Laxmi Bai Medical College ...

Jammu: A pregnant woman, who was turned away from the Primary Health Centre (PHC) Teryath due to the absence of a ...

USA: A recent research examining elderly patients (aged ≥75) with non-ST-segment-elevation acute coronary syndrome (ACS) ...

Japan: A recent phase 3, randomized, double-blind, placebo-controlled study published in the Journal of Dermatology has shown ...

A new study published in the International Journal of General Medicine found that a severe vitamin D deficit (<10 ng/mL) ...

A novel study published in the journal PLOS ONE highlighted the effects of hydroxychloroquine on cardiovascular risk factors ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

It is crucial to have the central venous catheters (CVCs) properly inserted to ensure effective treatment and reduce risks of ...

Night-shift work has long been linked to poor health outcomes, including increased risks of metabolic disorders such as ...

China: The RESCUE BT trial found that intravenous (IV) tirofiban administered before endovascular thrombectomy significantly ...